Editorial comment on: Vaccine therapy in patients with renal cell carcinoma. Clark PE (2009) Eur Urol 55: 1343-4 Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Pulaski BA, Ostrand-Rosenberg S (1998) Cancer Res 58: 1486-93 Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine. Sondak VK, Sosman JA (2003) Semin Cancer Biol 13: 409-15 Melacine: an allogeneic melanoma tumor cell lysate vaccine. Sosman JA, Sondak VK (2003) Expert Rev Vaccines 2: 353-68 Is bladder biopsy necessary at three or six months post BCG therapy? Highshaw RA, Tanaka ST, Evans CP, deVere White RW (2003) Urol Oncol 21: 207-9 Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide. Perambakam S, Hallmeyer S, Reddy S, Mahmud N, Bressler L, DeChristopher P, Mahmud D, Nunez R, Sosman JA, Peace DJ (2006) Cancer Immunol Immunother 55: 1033-42 Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Gómez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF (1998) Vaccine 16: 460-71 Update on active specific immunotherapy with melanoma vaccines. Conforti AM, Ollila DW, Kelley MC, Gammon G, Morton DL (1997) J Surg Oncol 66: 55-64
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.